Stereotaxis Stock Story

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Let me take a closer look at Stereotaxis revenue. Based on the latest financial disclosure, Stereotaxis reported 33.2 M of revenue. This is 99.56% lower than that of the Healthcare sector and 98.19% lower than that of the Medical Instruments & Supplies industry. The revenue for all United States stocks is 99.65% higher than that of Stereotaxis. As for Intuitive Surg we see revenue of 5.49 B, which is 199.0% higher than that of the Medical Instruments & Supplies

Sector 1.8 B

ISRG 5.5 B

	STXS	33.2 Million	0.45
	Sector	1.84 Billion	24.95
	ISRG	5.49 Billion	74.6

Chances of Stereotaxis to slide back

Potential upside is down to 4.88. It may connote a possible volatility fall. Stereotaxis exhibits very low volatility with skewness of -1.17 and kurtosis of 6.53. However, we advise investors to further study Stereotaxis technical indicators to make sure all market info is available and is reliable. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Stereotaxis' stock risk against market volatility during both bullying and bearish trends. The higher level of volatility that comes with bear markets can directly impact Stereotaxis' stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different stocks as prices fall.

Stereotaxis Implied Volatility

Our Final Takeaway

While some other entities in the medical instruments & supplies industry are either recovering or due for a correction, Stereotaxis may not be performing as strong as the other in terms of long-term growth potentials. While some retail investors may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Stereotaxis.